Labcorp Unveils Long-Term Outlook Driven by Specialty Testing
Article excerpt
Highlighted: the sentence this signal was extracted from
A LabCorp office in San Francisco. Photographer: Justin Sullivan/Getty Images Labcorp Holdings Inc. is providing an ambitious long-term plan for investors as the laboratory services company anticipates continued growth in personalized medicine. Labcorp estimates a compound annual revenue growth of 5% to 8% through 2029, the company said in a statement ahead of its investor day Thursday. Compound annual adjusted earnings per share is projected to increase 8.5% to 11.5% over the same time span.
